BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 28302159)

  • 1. A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis.
    Cooper-Knock J; Green C; Altschuler G; Wei W; Bury JJ; Heath PR; Wyles M; Gelsthorpe C; Highley JR; Lorente-Pons A; Beck T; Doyle K; Otero K; Traynor B; Kirby J; Shaw PJ; Hide W
    Acta Neuropathol Commun; 2017 Mar; 5(1):23. PubMed ID: 28302159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial TREM2 in amyotrophic lateral sclerosis.
    Xie M; Zhao S; Bosco DB; Nguyen A; Wu LJ
    Dev Neurobiol; 2022 Jan; 82(1):125-137. PubMed ID: 34874625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.
    Varghese AM; Ghosh M; Bhagat SK; Vijayalakshmi K; Preethish-Kumar V; Vengalil S; Chevula PC; Nashi S; Polavarapu K; Sharma M; Dhaliwal RS; Philip M; Nalini A; Alladi PA; Sathyaprabha TN; Raju TR
    J Neuroinflammation; 2020 Aug; 17(1):232. PubMed ID: 32762702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
    Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.
    Cady J; Koval ED; Benitez BA; Zaidman C; Jockel-Balsarotti J; Allred P; Baloh RH; Ravits J; Simpson E; Appel SH; Pestronk A; Goate AM; Miller TM; Cruchaga C; Harms MB
    JAMA Neurol; 2014 Apr; 71(4):449-53. PubMed ID: 24535663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.
    El Oussini H; Bayer H; Scekic-Zahirovic J; Vercruysse P; Sinniger J; Dirrig-Grosch S; Dieterlé S; Echaniz-Laguna A; Larmet Y; Müller K; Weishaupt JH; Thal DR; van Rheenen W; van Eijk K; Lawson R; Monassier L; Maroteaux L; Roumier A; Wong PC; van den Berg LH; Ludolph AC; Veldink JH; Witting A; Dupuis L
    Acta Neuropathol; 2016 Mar; 131(3):465-80. PubMed ID: 26744351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling TREM2 expression in amyotrophic lateral sclerosis.
    Jericó I; Vicuña-Urriza J; Blanco-Luquin I; Macias M; Martinez-Merino L; Roldán M; Rojas-Garcia R; Pagola-Lorz I; Carbayo A; De Luna N; Zelaya V; Mendioroz M
    Brain Behav Immun; 2023 Mar; 109():117-126. PubMed ID: 36681358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological profile of long-duration amyotrophic lateral sclerosis in military Veterans.
    Spencer KR; Foster ZW; Rauf NA; Guilderson L; Collins D; Averill JG; Walker SE; Robey I; Cherry JD; Alvarez VE; Huber BR; McKee AC; Kowall NW; Brady CB; Stein TD
    Brain Pathol; 2020 Nov; 30(6):1028-1040. PubMed ID: 32633852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting disease specific spinal motor neurons and glia in sporadic ALS.
    Dachet F; Liu J; Ravits J; Song F
    Neurobiol Dis; 2019 Oct; 130():104523. PubMed ID: 31276795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis.
    Rossi C; Cusimano M; Zambito M; Finardi A; Capotondo A; Garcia-Manteiga JM; Comi G; Furlan R; Martino G; Muzio L
    Cell Death Dis; 2018 Feb; 9(2):250. PubMed ID: 29445154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase-1 expressing microglia in close proximity to motor neurons were increased early in disease progression in canine degenerative myelopathy, a model of amyotrophic lateral sclerosis.
    Toedebusch CM; Snyder JC; Jones MR; Garcia VB; Johnson GC; Villalón EL; Coates JR; Garcia ML
    Mol Cell Neurosci; 2018 Apr; 88():148-157. PubMed ID: 29408267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells.
    Edri-Brami M; Rosental B; Hayoun D; Welt M; Rosen H; Wirguin I; Nefussy B; Drory VE; Porgador A; Lichtenstein RG
    PLoS One; 2012; 7(5):e35772. PubMed ID: 22666317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis.
    Maniatis S; Äijö T; Vickovic S; Braine C; Kang K; Mollbrink A; Fagegaltier D; Andrusivová Ž; Saarenpää S; Saiz-Castro G; Cuevas M; Watters A; Lundeberg J; Bonneau R; Phatnani H
    Science; 2019 Apr; 364(6435):89-93. PubMed ID: 30948552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.
    Nikel LM; Talbot K; Vahsen BF
    Bioessays; 2024 Jul; 46(7):e2400054. PubMed ID: 38713169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation.
    Liu J; Allender E; Wang J; Simpson EH; Loeb JA; Song F
    Neurobiol Dis; 2018 Mar; 111():118-126. PubMed ID: 29278738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.